Edition:
United Kingdom

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

37.00USD
24 May 2019
Change (% chg)

$0.19 (+0.52%)
Prev Close
$36.81
Open
$37.00
Day's High
$37.36
Day's Low
$36.47
Volume
83,361
Avg. Vol
175,310
52-wk High
$73.90
52-wk Low
$22.23

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.33 -0.929
FY 2018 Dec '18 0.12 -0.920
Sep '18 0.56 -1.070
Jun '18 1.09 -0.819
Mar '18 1.36 -0.617
FY 2017 Dec '17 32.33 0.003
Sep '17 2.39 -0.616
Jun '17 3.58 -0.559
Mar '17 2.70 -0.541
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 9 2.72 7.50 0.00 5.50
Quarter Ending Sep-19 9 1.44 5.00 0.00 5.50
Year Ending Dec-19 11 5.91 15.30 0.30 21.19
Year Ending Dec-20 11 17.48 109.30 0.00 23.90
Earnings (per share)
Quarter Ending Jun-19 11 -0.92 -0.73 -1.08 -0.71
Quarter Ending Sep-19 11 -0.98 -0.81 -1.10 -0.73
Year Ending Dec-19 12 -3.88 -3.17 -4.66 -3.04
Year Ending Dec-20 12 -4.34 -3.24 -5.22 -3.66
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 93.20 35.48
P/E High - Last 5 Yrs. -- 165.14 57.43
P/E Low - Last 5 Yrs. -- 51.92 28.10
Beta -- 1.21 0.95
Price to Sales (TTM) 934.89 40.13 9.28
Price to Book (MRQ) 5.13 11.48 4.15
Price to Tangible Book (MRQ) 5.16 16.72 4.94
Price to Cash Flow (TTM) -- 61.14 24.38
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.68
Dividend Yield - 5 Year Avg -- 0.06 1.30
Dividend 5 Year Growth Rate -- 0.94 6.71
Payout Ratio(TTM) -- 1.56 35.42

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -75.85 59.08 16.40
Sales (TTM) vs TTM 1 Yr. Ago -94.72 46.19 8.26
Sales - 5 Yr. Growth Rate -- 32.98 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -50.64 -9.33 19.71
EPS (TTM) vs TTM 1 Yr. Ago -108.98 -- --
EPS - 5 Yr. Growth Rate -- 22.17 7.23
Capital Spending - 5 Yr. Growth Rate -- 24.87 8.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.77 2.43
Current Ratio (MRQ) 15.84 3.84 3.36
LT Debt to Equity (MRQ) 0.00 7.71 14.37
Total Debt to Equity (MRQ) 0.00 20.81 19.78
Interest Coverage (TTM) -29.44 32.37 13.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 22.42 50.23
Gross Margin - 5 Yr. Avg. -- 59.23 51.31
EBITD Margin (TTM) -8,431.71 -- --
EBITD - 5 Yr. Avg -- -16.11 15.84
Operating Margin (TTM) -8,613.61 -116.39 -4.60
Operating Margin - 5 Yr. Avg. -- -31.95 11.09
Pre-Tax Margin (TTM) -8,812.66 -116.40 -4.95
Pre-Tax Margin - 5 Yr. Avg. -- -34.49 15.89
Net Profit Margin (TTM) -8,839.02 -121.99 -8.72
Net Profit Margin - 5 Yr. Avg. -- -39.40 11.14
Effective Tax Rate (TTM) -- 17.16 19.94
Effective Tax Rate - 5 Yr. Avg. -- 18.91 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 11,138 8,861,170 746,541,307
Net Income/Employee (TTM) -984,516 1,554,572 87,192,468
Receivable Turnover (TTM) 2.63 11.38 5.67
Inventory Turnover (TTM) -- 2.45 3.66
Asset Turnover (TTM) 0.00 0.33 0.79

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -42.44 6.13 9.44
Return on Assets - 5 Yr. Avg. -- 6.07 10.47
Return on Investment (TTM) -44.62 7.47 11.75
Return on Investment - 5 Yr. Avg. -- 7.95 13.33
Return on Equity (TTM) -55.24 7.94 16.52
Return on Equity - 5 Yr. Avg. -- 9.00 14.90
  1 Year 3 Year 5 Year
Sales % -92.38 132.99 --
EPS (TTM) % -101.56 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CRISPR Therapeutics AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.80 -6.17 77 7
13 Week 16.83 15.45 99 16
26 Week 3.76 -3.35 99 7
52 Week -46.88 -48.73 67 12
YTD 29.51 14.88 99 4
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.11%
# of Holders: 225
Total Shares Held: 26,510,568
3 Mo. Net Change: 3,858,364
# New Positions: 46
# Closed Positions: 29
# Increased Positions: 100
# Reduced Positions: 71
# Net Buyers: 29
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.